Makoto Ota
Founder bei WELBE, INC.
Vermögen: 39 Mio $ am 31.03.2024
Profil
Makoto Ota is the founder of Welbe, Inc. where he holds the title of President & Representative Director since 2011.
He is currently a Director at Welbe Healthcare, Inc. since 2021.
Mr. Ota was also a Director at tella, Inc. in the past.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
WELBE,INC.
20,00% | 27.03.2024 | 5 512 154 ( 20,00% ) | 39 Mio $ | 31.03.2024 |
Aktive Positionen von Makoto Ota
| Unternehmen | Position | Beginn |
|---|---|---|
| WELBE, INC. | Founder | 01.12.2011 |
| Welbe Healthcare, Inc. | Director/Board Member | 01.06.2021 |
Ehemalige bekannte Positionen von Makoto Ota
| Unternehmen | Position | Ende |
|---|---|---|
| TELLA, INC. | Director/Board Member | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| Welbe, Inc. | |
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
